Home
Orphan Drugs and Rare Diseases
19 October - 20 October 2016
Orphan Drugs and Rare Diseases

SAE Media Group is proud to announce the return of their 5th annual Orphan Drugs event to London on the 19th -20th October 2016!


The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
In the past year (2015) alone, the Food and Drug Administration have approved 21 new entities. The orphan drug market has seen a dramatic increase in pharmacologic cures for rare diseases, such as Gaucher’s disease (Cerezyme/Imiglucerase), atypical Hemolytic Uremic Syndrome (Soliris/Eculizumab) and Non-Hodgkin’s Lymphoma (Rituxan/Rituximab). Such entities have revolutionized medicine and paved the way for other drug candidates to enter this space. *


SAE Media Group’s 5th annual Orphan Drugs event will bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.
 

* http://www.businesswire.com/news/home/20160406005885/en/Global-Orphan-Drug-Market-Set-Grow-191
*http://blogs.wsj.com/experts/2016/04/13/the-orphan-drug-acts-successes-outweigh-its-failures/
 

FEATURED SPEAKERS

Robert Karl

Robert Karl

Partner, RBV Capital
Sheela Upadhyaya

Sheela Upadhyaya

Associate Director - Highly Specialised Technologies , National Institute for Health and Care Excellence
Tim  Miller

Tim Miller

President & CEO, Abeona Therapeutics
Tony Hall

Tony Hall

Therapeutic Area Head, Orphan Diseases, Mereo BioPharma

Aaron Barzey

CEO, ADB Medical
Aaron Barzey

Ad Rietveld

Founder & Director, RJW & partners Ltd
Ad  Rietveld

Bindhya Cariappa

Chief Scientific Officer & Executive Vice President for Turkey. MEA & APAC., ClinTec International Ltd
Bindhya Cariappa

Cecile De Coster

Associate Director, Regulatory Affairs, Alexion Pharma International SÓrl
Cecile De Coster

Chris Adams

CEO, Cydan
Chris Adams

Daniel O'Connor

Medical Assessor, MHRA
Daniel O'Connor

Diego Ardigo

ATMP Project and Clinical Program Leader, Chiesi Farmaceutici SpA
Diego Ardigo

Gulce Belgin

Director, Proceutica
Gulce  Belgin

Judith Ng-Cashin

Chief Scientific Officer, INC Research
Judith  Ng-Cashin

Michelle Berg

Vice President, Patient Advocacy, Abeona Therapeutics
Michelle Berg

Natalie Thomas

Consultant, Clinical Network Services (UK) Ltd
Natalie Thomas

Oliver Timmis

CEO, AKU Society
Oliver Timmis

Richard Pye

Senior Director, Corporate Affairs & Communications, Summit Therapeutics
Richard Pye

Rick Thompson

Scientific Officer, Findacure
Rick Thompson

Robert Karl

Partner, RBV Capital
Robert Karl

Sheela Upadhyaya

Associate Director - Highly Specialised Technologies , National Institute for Health and Care Excellence
Sheela Upadhyaya

Tim Miller

President & CEO, Abeona Therapeutics
Tim  Miller

Tim Guilliams

Founder & CEO, Healx
Tim Guilliams

Tony Hall

Therapeutic Area Head, Orphan Diseases, Mereo BioPharma
Tony Hall

sponsors

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Strategy and profiling: laying the foundations for success

• The importance of a target product profi le
• Understanding your regulatory environment
• Knowing your patient population: the value of
natural history studies and patient registries

Alex Bloom

Alex Bloom, Director of Regulatory Affairs, Cell Medica Ltd

Diego Ardigo

Diego Ardigo, Project Lead, CHIESI FARMACEUTICI S.p.A.

clock

11:00

Morning Coffee

clock

11:30

Development, approval and marketing

• Clinical development in small populations:
opportunities and limitations
• Expedited development pathways and early
access schemes
• Developing a market access strategy and the
value of real world data

Alex Bloom

Alex Bloom, Director of Regulatory Affairs, Cell Medica Ltd

Diego Ardigo

Diego Ardigo, Project Lead, CHIESI FARMACEUTICI S.p.A.

clock

12:30

End of Workshop

clock

13:30

Registration & Coffee

clock

14:00

Opening remarks

Ad  Rietveld

Ad Rietveld, Ad Rietveld, RJW & partners Ltd

John Spoors

John Spoors, Senior Consultant, RJW & partners Ltd

clock

14:10

Session 1: Orphan Drugs: Why is regulatory orphan drug status still not enough to achieve market access at acceptable prices?

Ad  Rietveld

Ad Rietveld, Ad Rietveld, RJW & partners Ltd

John Spoors

John Spoors, Senior Consultant, RJW & partners Ltd

clock

14:50

Session 2: The payer perspective: Orphan products are what we’ve been waiting for!

Ad  Rietveld

Ad Rietveld, Ad Rietveld, RJW & partners Ltd

John Spoors

John Spoors, Senior Consultant, RJW & partners Ltd

clock

15:30

Afternoon Tea

clock

16:40

Session 3: How to ensure that evidence for orphan drugs is relevant to the payer

Ad  Rietveld

Ad Rietveld, Ad Rietveld, RJW & partners Ltd

John Spoors

John Spoors, Senior Consultant, RJW & partners Ltd

clock

17:00

Chairman’s Closing Remarks and Close of Day One

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Tim  Miller

Tim Miller, President & CEO, Abeona Therapeutics

clock

9:10

Market access for orphan drugs

Sheela Upadhyaya

Sheela Upadhyaya, Associate Director - Highly Specialised Technologies , National Institute for Health and Care Excellence

• A brief outline of the NICE Highly Specialised Technology
(HST) Evaluation process
• Topic selection and NICE HST Prioritisation Criteria
• Working with stakeholders: including patient support
organisations

clock

9:45

Regulatory challenges for orphan products: Focus on emerging markets

Natalie Thomas

Natalie Thomas, Consultant, Clinical Network Services (UK) Ltd

- Review of orphan legislation and incentives in emerging markets
- Regulatory and market access issues for development of orphan drugs in emerging markets
- Considerations for global development and filing strategy

clock

10:20

Morning Coffee

clock

10:40

Global orphan drug regulatory strategy

Aaron Barzey

Aaron Barzey, CEO, ADB Medical

• Global orphan drug regulations
• Joint FDA-EMA submissions
 

clock

11:15

Development of orphan drugs to prevent, diagnose and treat rare diseases

Tim  Miller

Tim Miller, President & CEO, Abeona Therapeutics

• Reviewing the challenges of orphan drugs development
and creating workable solutions of to overcome them
• How to establish early access to orphan drugs
• Analysing what regulatory bodies can do to support
companies investing in these drugs

clock

11:50

Challenges with paediatric orphan drug development

Cecile De Coster

Cecile De Coster, Associate Director, Regulatory Affairs, Alexion Pharma International SÓrl

• Complex Issues in developing drugs and biological
products for rare diseases
• How to accelerate the development of therapies for
paediatric rare diseases
• Methods to overcome the challenges of trial design

clock

12:25

Networking Lunch

clock

13:25

Rare disease clinical trials: Challenges & opportunities

Bindhya Cariappa

Bindhya Cariappa, Chief Scientific Officer & Executive Vice President for Turkey. MEA & APAC., ClinTec International Ltd

clock

14:05

Orphan drug industry and venture capital – key factors for a successful partnership

Robert Karl

Robert Karl, Partner, RBV Capital

• Investment in orphan drugs industry is a very attractive fi t
for venture capital
• What venture capital is looking for in orphan drug
Industry
• Key factors you should to consider when searching for
venture capital

clock

14:40

An alternative development path for rare disease therapeutics

Chris Adams

Chris Adams, CEO, Cydan

• VC- funded biotech or pharma are the traditional partners for rare disease drug development
• A new model has evolved- focused, well funded, nimble - the rare disease accelerator
• Experience of the accelerator- 3 years of data

clock

15:15

A case study of patient foundations and industry working together

Michelle Berg

Michelle Berg, Vice President, Patient Advocacy, Abeona Therapeutics

• Education is key and it’s a two way street.
• Working together at all stages, ensuring effective
collaboration
• Providing consistent and accurate information

clock

15:50

Afternoon Tea

clock

16:15

A patient group’s perspective on patient recruitment and retention

Oliver Timmis

Oliver Timmis, CEO, AKU Society

• Patient recruitment in Europe
• How to maximise patient retention
• Why patient groups can be an effective may to
manage the patient input of clinical trials

clock

16:50

Developing a new model to fund drug repurposing for rare diseases.

Rick Thompson

Rick Thompson, Scientific Officer, Findacure

- the benefits of drug repurposing
- The use of a social impact bond to fund rare disease drug repurposing with a core aim of saving the NHS money.
- assessing the current costs of rare diseases to validate the  social impact bond model
 

clock

17:25

Chairman’s Closing Remarks and Close of Day One

Tim  Miller

Tim Miller, President & CEO, Abeona Therapeutics

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Tim  Miller

Tim Miller, President & CEO, Abeona Therapeutics

clock

9:10

Building a patient centric model for rare disease drug discovery

Tim Guilliams

Tim Guilliams, Founder & CEO, Healx

-          Role of patient groups in drug development
-          Applying artificial intelligence to drug repurposing
-          Supporting non-for-profit drug discovery
 

clock

9:45

Rare disease clinical research: Collaboration the key to success

Judith  Ng-Cashin

Judith Ng-Cashin, Chief Scientific Officer, INC Research

· Focus on the patient experience and early engagement of patients and their advocates drives data quality and access to novel therapies
· Partnership with quality and experienced sites, leveraging their clinical expertise while providing operational support ensures quality despite complexity
· Fostering collaboration between patient advocacy groups, specialized sites, medical and scientific leaders, and operational experts in rare diseases accelerates drug development and patient access to medicines in rare diseases

 

clock

10:25

Morning Coffee

clock

10:45

The challenges in defending orphan products pricing

Ad  Rietveld

Ad Rietveld, Founder & Director, RJW & partners Ltd


• Pricing models for orphan drugs
• The changing environment for contracting options
• Increasing the likelihood of acceptance of contracting options by payers

clock

11:20

A new business model for developing rare diseases treatments

Tony Hall

Tony Hall, Therapeutic Area Head, Orphan Diseases, Mereo BioPharma

The Mereo BioPharma business model
o acquisition of assets
o funding the programs
o what has been achieved to date
- Case study: osteogenesis imperfecta
o the need for an effective therapy in OI
o anti-sclerostin antibody as a potential treatment for OI
o the pathway to registration
 

clock

11:55

Advancing therapies for Duchenne Muscular Dystrophy (DMD)

Richard Pye

Richard Pye, Senior Director, Corporate Affairs & Communications, Summit Therapeutics

• Utrophin modulation has the potential to treat all boys
and young men with DMD, regardless of their underlying
dystrophin gene mutation
• PhaseOut DMD, a Phase 2 trial of lead utrophin
modulator, ezutromid, expected to report 24 week
biopsy data from initial group of patients in January 2017
– could provide fi rst signs of proof of mechanism
• Mechanism of action and results to date

 

clock

12:30

Networking Lunch

clock

14:05

The rise of one-off gene and cell therapy treatments for rare diseases: is the future commercially viable?

Diego Ardigo

Diego Ardigo, ATMP Project and Clinical Program Leader, Chiesi Farmaceutici SpA

• Post-approval commitments, pricing & reimbursement, and patient access for gene and cell therapies: key considerations of the bumpy journey after marketing authorization.
• Development considerations in demonstrating long-term efficacy for advanced therapies in the orphan drug space.
• Critical issues in the generation and evaluation of value for advanced therapies. Are the currently available tools and approaches adequate? Is there a reasonable return on today’s investments in advanced therapies?
 

clock

14:40

Afternoon Tea

clock

15:00

Panel Discussion:How can partnerships improve the orphan drug field?

• How to make a multi-stakeholder partnership successful?
• What role does each stakeholder play?
• How can collaboration/partnership improve orphan drugs access to  market?
 

Tim  Miller

Tim Miller, President & CEO, Abeona Therapeutics

• How to make a multi-stakeholder partnership successful?
• What role does each stakeholder play?
• How can collaboration/partnership improve orphan drugs access to  market?
 

Daniel O'Connor

Daniel O'Connor, Medical Assessor, MHRA

Michelle Berg

Michelle Berg, Vice President, Patient Advocacy, Abeona Therapeutics

clock

15:35

Why Turkey should feature early in launch plans for orphan drugs

Gulce  Belgin

Gulce Belgin, Director, Proceutica

- A key emerging market.
-Situation with Rare Diseases
- Regulatory framework
-Options for market access of orphan drugs
 

clock

16:10

Chairman’s Closing Remarks and Close of Day Two

Tim  Miller

Tim Miller, President & CEO, Abeona Therapeutics


CEO
ADB Medical
Founder & Director
RJW & partners Ltd
Chief Scientific Officer & Executive Vice President for Turkey. MEA & APAC.
ClinTec International Ltd
Associate Director, Regulatory Affairs
Alexion Pharma International SÓrl
CEO
Cydan
Medical Assessor
MHRA
ATMP Project and Clinical Program Leader
Chiesi Farmaceutici SpA
Director
Proceutica
Chief Scientific Officer
INC Research
Vice President, Patient Advocacy
Abeona Therapeutics
Consultant
Clinical Network Services (UK) Ltd
CEO
AKU Society
Senior Director, Corporate Affairs & Communications
Summit Therapeutics
Scientific Officer
Findacure
Partner
RBV Capital
Associate Director - Highly Specialised Technologies
National Institute for Health and Care Excellence
President & CEO
Abeona Therapeutics
Founder & CEO
Healx
Therapeutic Area Head, Orphan Diseases
Mereo BioPharma

Sponsors and Exhibitors

Official Media Partner

Supporters

Workshops

Paving the way for achieving orphan drug market access

Paving the way for achieving orphan drug market access

Holiday Inn Kensington Forum
18 October 2016
London, United Kingdom

Preliminary List of Attendees 2016

Download

Delegate Profile List 2015-2016

Download

An Interview with Dr Tim Miller, President and CEO of Abeona Therapeutics

Download

An interview with Robert Karl, Partner, RBV Capital

Download

Sponsors and Exhibitors


ClinTec International

Sponsors and Exhibitors
http://www.clintec.com/

ClinTec International is an innovative, mid-sized, full-service global Contract Research Organisation and Functional Service Provider specialising in Oncology and Rare Diseases. With a local presence in over 50 countries, ClinTec has built a world-class team of permanent employees and country management delivering a high-quality, customer-centric service. As an entrepreneurial and award winning business, ClinTec is at the forefront of conducting clinical research programmes worldwide, including unique access to emerging markets such as Turkey, Middle East and Africa. ClinTec customises each engagement through a consultative and flexible approach, aligning every solution and service to the client’s individual requirements.


INC Research

Sponsors and Exhibitors
http://www.incresearch.com/

INC Research (Nasdaq: INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was named “Best Contract Research Organization” in December 2015 by an independent panel for Scrip Intelligence, and ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries.

Media Partners


RareBase

Official Media Partner
http://www.rarebase.co.uk

The RareBase Networking Portal links people and companies throughout the world with an interest in rare and paediatric diseases.


Global Biodefense

Official Media Partner
http://www.globalbiodefense.com/

Global Biodefense publishes the latest news on vaccine and therapeutics countermeasure development, biosurveillance and detection technologies, food safety and biosecurity, and CBRN incident preparedness and response. Visit our website to access daily news updates, organization profiles, conference listings, and the latest in funding opportunities for advancing biodefense technology.


Personalize My Medicine

Official Media Partner
http://www.personalizemymedicine.com/

Personalize My Medicine (PMM) places people and patients at center by informing them of the latest advances in medical innovation relevant to their condition and promoting research and innovation for unmet medical needs through our dedicated crowdfunding platform designed for both patients and innovators. PMM researches, informs, and facilitates advancements in healthcare for anyone who wants to be more proactive about their own health by conducting surveys, setting up research networks, crowdfunding for medical innovation, and promoting medical innovation for orphan diseases. Please be invited to www.personalizemymedicine.com to find out more. https://www.youtube.com/watch?v=ZllKlRuG2EQ&app=desktop

Media Partners


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Select Science

Supporters
http://www.selectscience.net/

SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


Bentham Science

Supporters
http://www.benthamscience.com/

Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here


Gate2Biotech

Supporters
http://www.gate2biotech.com

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


Labiotech.eu

Supporters
https://goo.gl/DRE2Gp

Labiotech.eu is the leading digital media covering the European Biotech industry. Over 100,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!


BioPharm Insight

Supporters
http://www.biopharminsight.com

BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


Pharmiweb

Supporters
http://www.pharmiweb.com

Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


Drug Target Review

Supporters
http://www.drugtargetreview.com

Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


Taylor & Francis Group

Supporters
http://bit.ly/TF-Med

As one of the world’s leading publishers of scholarly journals, books, eBooks, reference works, and databases, Taylor & Francis Group partners with researchers, scholarly societies, universities, and libraries worldwide to bring knowledge to life.


Drug Discovery Today

Supporters
http://www.drugdiscoverytoday.com/

Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


Swiss Biotech Association

Supporters
http://www.swissbiotech.org/

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


Pharmavision

Supporters
http://www.pharmavision.co.uk

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


Biosave

Supporters
http://www.Biosave.com

Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


Farmavita

Supporters
https://farmavitar.com

FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


Pharmacircle

Supporters
http://www.pharmacircle.com

PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


European Biopharmaceutical Review

Supporters
http://www.samedanltd.com/magazine/12

European Biopharmaceutical Review (EBR) is a magazine dedicated to the biopharmaceutical and biotech industries. Each quarterly edition features articles from key opinion leaders on research, drug discovery and development, biomanufacturing, outsourcing and more on the science and business of the sectors. EBR also features insightful interviews, reviews and event information to form a strong B2B platform. Read EBR in print, online, or via the Samedan app.


Absave

Supporters
http://www.absave.com

Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


pharmaphorum

Supporters
http://www.pharmaphorum.com

pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


Drug Development Technology

Supporters
http://www.drugdevelopment-technology.com

Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


Pharmaceutical Technology

Supporters
http://www.pharmaceutical-technology.com

Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


International Pharmaceutical Industry

Supporters
http://www.ipimediaworld.com

IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


British Pharmacological Society

Supporters
http://www.bps.ac.uk

The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


CLocate

Supporters
http://www.clocate.com

Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's website and more...


Labsave

Supporters
http://www.labsave.com

Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


Technology Networks

Supporters
http://go.technologynetworks.com/subscribe-to-newsletters

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


PMR

Supporters
http://www.pmrcorporate.com

PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


Farmavita

Supporters
https://farmavitar.com

FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


ASD MEDIA

Supporters
http://www.asd-network.com

Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
  • Be informed on the latest market developments; www.asd-network.com
  • Find the latest business news; www.asd-network.com
  • Find the upcoming events; www.asd-network.com
  • Find companies and organizations; www.asdsource.com
  • Distribute news globally. www.asdwire.com
The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

For more detailed information please contact with: ASD MEDIA
Stefan.koopman@asdmedia.nl


GBI

Supporters
http://www.gbihealth.com/

GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


BioChem Adda

Supporters
https://www.biochemadda.com/

BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


CanBiotech

Supporters
http://www.canbiotech.com

CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.

Holiday Inn Kensington Forum

97 Cromwell Road
London SW7 4DN
United Kingdom

Holiday Inn Kensington Forum

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download

Title


Description

Download

Title


Description


Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

Group Booking

Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

Fill in your details to download the brochure

By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.